Gynecological Cancer: Clinical Research and Personalized Medicine

A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Clinical Medicine, Cell, and Organism Physiology".

Deadline for manuscript submissions: 10 July 2024 | Viewed by 146

Special Issue Editor


E-Mail Website
Guest Editor
1. Department of Woman’s and Child’s Health, Obstetrics and Gynecological Unit, San Camillo-Forlanini Hospital, Rome, Italy
2. Department of Medical and Surgical Sciences and Translational Medicine, PhD Course in “Translational Medicine and Oncology”, Sapienza University of Rome, Viale dell’Università, 37, 00185 Rome, Italy
Interests: gynecologic oncology; personalized medicine; women’s and children’s health; urological sciences

Special Issue Information

Dear Colleagues,

Thanks to the advances in science and evidence-based medicine, the personalized diagnostic and therapeutic path is mandatory for all patients.

Although this concept can be extended to all branches of medicine, it is even more important in the gynecological and obstetric field, where a wide range of diagnostic and treatment options are available. Tailored treatment selection is crucial, taking into account each woman’s medical history and the unique emotional and psychological concerns that are common for women during their entire life.

Overall, clinical research and personalized medicine hold the potential to revolutionize women’s healthcare by providing more effective and targeted treatments that are tailored to individual women’s unique characteristics and needs.

I am honored to invite you to consider this Special Issue for submission of original research, meta-analysis and review papers about clinical research and personalized medicine in gynecological cancer.

Dr. Ottavia D’oria
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • gynecological cancer
  • cancer prevention
  • screening programs
  • gynecologic oncology
  • diagnostic and therapeutic path
  • women’s health
  • personalized medicine

Published Papers

This special issue is now open for submission.
Back to TopTop